NewsAvi Kapoor
Connect Biopharma Holdings
CNTB · NASDAQ
$0.8752−$0.0246 (−2.73%)TodayMarket closed ·
Prev close $0.8998
Latest news
- NewsVandana Singh
Connect Biopharma Reports Significant Drop In Treatment Failure With New COPD Therapy
- Press releaseGlobe Newswire
3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
- Press releaseGlobe Newswire
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
- NewsVandana Singh
Why Is Connect Biopharma Stock Trading Lower on Tuesday?
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseGlobe Newswire
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation
- Press releaseGlobe Newswire
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseGlobe Newswire
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
- Press releaseGlobe Newswire
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
- Press releaseGlobe Newswire
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
- Press releasePRNewswire
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
Connect Biopharma Hldgs Q2 EPS $(0.23) Misses $(0.22) Estimate, Sales $48.000K Down From $24.116M YoY
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseGlobe Newswire
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
- Press releaseGlobe Newswire
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releaseGlobe Newswire
Connect Biopharma to Present at Two Upcoming Investor Conferences
- News
Connect Biopharma Hldgs H1 EPS $0.14 Up From $(0.55) YoY, Sales $24.12M
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.